Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
19/03/2026 12:30
Removes reference to estimate for Q4 adjusted net income March 19 (Reuters) - Theravance Biopharma Q4 adjusted net income USD 3.131 million * Q4 net income USD 61.024 million * Q4 revenue USD 45.9 million vs. IBES estimate USD 58.5 million * Q4 EPS USD 1.15 ((Reuters.Briefs@thomsonreuters.com))
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy